About Snig Pharma
Snig Pharma is a Healthcare company. Pharmaceutical products and services focused on CNS, Cardio-Diabetic, Critical Care, and General segments. The company has 18 employees. Its Indian entity Snig Pharma Private Limited reported revenue of ₹6.94 Cr. Snig Pharma offers products and services including Valnigo and Snigmin. Its focus areas include Manufacturing, Pharmaceutical Production, Critical Care Supplies and Pharmaceuticals.
Company details
Snig Pharma Pvt. Ltd. is identified as a pharmaceutical company that provides a portfolio of products designed to prevent, treat, and cure ailments across therapeutic segments including CNS, Cardio-Diabetic, Critical Care, and General. High-quality and affordable medicines are made accessible to those in need through partnerships with healthcare providers, governments, and non-governmental organizations. A commitment is maintained towards patients, medical professionals, employees, business associates, and shareholders to address ever-increasing health needs, emphasizing quality, reliability, and sustainability in manufacturing processes.
- Employees 18
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website snigpharma.com
- Legal Name Snig Pharma Pvt. Ltd
- Date of Incorporation 18 Aug, 2015
- Jurisdiction Karnataka, India
- Indian entity revenue₹6.94 Cr
FY 2025 · -4% YoY
- Indian entity net profit₹38.6 Lakh
FY 2025 · 6% margin
- Indian entity EBITDA₹52.5 Lakh
FY 2025 · 8% margin
- Employee Count18
Associated legal entities of Snig Pharma
Snig Pharma operates through Snig Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Snig Pharma Private Limited CIN U52590KA2015PTC082351 | Active | 18 Aug 2015 | Bangalore, Karnataka | ₹6.9 Cr | 18 | 5 | View details |
Products & Services of Snig Pharma
Snig Pharma offers a comprehensive portfolio of products and services, including Valnigo and Snigmin.
Valnigo is utilized for treating ailments in therapeutic segments like CNS.
Snigmin is employed for general health purposes across various therapeutic areas.
Board of directors of Snig Pharma Private Limited (Snig Pharma)
Snig Pharma Private Limited is the primary company behind Snig Pharma. The board of Snig Pharma Private Limited currently have 5 directors; the longest-serving is Poornima Patil, appointed in 2015. 10 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Poornima Patil DIN 07160195 | Director | 18 Aug 2015 | 11 yrs 2 mo | Snig Pharma Private Limited |
| Ravi Subbanna Chandakavadi DIN 07984470 | Director | 25 Nov 2017 | 8 yrs 11 mo | Snig Pharma Private Limited |
| Marilinge Gowda Vivekananda DIN 07794342 | Director | 25 Nov 2017 | 8 yrs 11 mo | Snig Pharma Private Limited |
| Raghukumar Jogad DIN 07985292 | Director | 25 Nov 2017 | 8 yrs 11 mo | Snig Pharma Private Limited |
| Davanagere Ravindra Santhosh DIN 11596646 | Additional Director | 10 Mar 2026 | 7 mo | Snig Pharma Private Limited |
Financials of Snig Pharma
Figures of Snig Pharma Private Limited, the primary company behind Snig Pharma, for FY 2025. Revenue was ₹6.94 Cr (-4% year on year). Net profit was ₹38.6 Lakh (6% margin). EBITDA was ₹52.5 Lakh (8% margin). Revenue has grown at a compounded annual rate of +4% over three years and +6% over five years.
- ₹6.94 CrRevenue · FY 2025 · -4% YoY
- ₹38.6 LakhNet profit · 6% margin
- ₹52.5 LakhEBITDA · 8% margin
- ₹3.26 CrPaid-up capital
- 18Employees (provident fund records)
- +4%Revenue CAGR, 3 years
- +6%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Snig Pharma Private Limited are on its company page.
Detailed financial statements for Snig Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Snig Pharma
Snig Pharma has 18 employees.
The primary company behind Snig Pharma, Snig Pharma Private Limited, reported revenue of ₹6.94 Cr for FY 2025, down 4% year on year.
Snig Pharma Pvt. Ltd. is identified as a pharmaceutical company that provides a portfolio of products designed to prevent, treat, and cure ailments across therapeutic segments including CNS, Cardio-Diabetic, Critical Care, and General. High-quality and affordable medicines are made accessible to those in need through partnerships with healthcare providers, governments, and non-governmental organizations. A commitment is maintained towards patients, medical professionals, employees, business associates, and shareholders to address ever-increasing health needs, emphasizing quality, reliability, and sustainability in manufacturing processes.
Snig Pharma offers Valnigo and Snigmin.
Snig Pharma operates through Snig Pharma Private Limited.
The legal entities of Snig Pharma currently have 5 directors, including Ravi Subbanna Chandakavadi, Marilinge Gowda Vivekananda, Poornima Patil and others.